Elena P. Calandre

2.8k total citations
67 papers, 2.0k citations indexed

About

Elena P. Calandre is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Elena P. Calandre has authored 67 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Psychiatry and Mental health, 28 papers in Pharmacology and 13 papers in Clinical Psychology. Recurrent topics in Elena P. Calandre's work include Fibromyalgia and Chronic Fatigue Syndrome Research (41 papers), Musculoskeletal pain and rehabilitation (25 papers) and Pain Management and Placebo Effect (11 papers). Elena P. Calandre is often cited by papers focused on Fibromyalgia and Chronic Fatigue Syndrome Research (41 papers), Musculoskeletal pain and rehabilitation (25 papers) and Pain Management and Placebo Effect (11 papers). Elena P. Calandre collaborates with scholars based in Spain, Canada and United States. Elena P. Calandre's co-authors include Fernando Rico‐Villademoros, Mahmoud Slim, Juan M. Garcia‐Leiva, Javier Luis López Hidalgo, C.M. Rodriguez‐Lopez, Rocío Molina-Barea, Javier Ballesteros, Mónika Salgueiro, Antonio Verdejo‐García and Antoine Bechara and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Psychiatry and Pain.

In The Last Decade

Elena P. Calandre

64 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elena P. Calandre Spain 27 1.3k 760 358 323 240 67 2.0k
Fernando Rico‐Villademoros Spain 30 1.9k 1.5× 759 1.0× 363 1.0× 182 0.6× 535 2.2× 80 2.8k
Uma Sharma United States 16 1.1k 0.8× 1.1k 1.5× 1.2k 3.4× 607 1.9× 75 0.3× 25 2.7k
Michael Spaeth Germany 15 1.0k 0.8× 786 1.0× 222 0.6× 251 0.8× 144 0.6× 30 1.5k
Henning Værøy Norway 14 1.1k 0.8× 792 1.0× 320 0.9× 309 1.0× 141 0.6× 33 1.5k
Madelaine M. Wohlreich United States 30 1.7k 1.3× 2.1k 2.8× 564 1.6× 680 2.1× 253 1.1× 72 3.1k
Luke Parkitny United States 16 348 0.3× 725 1.0× 469 1.3× 179 0.6× 161 0.7× 27 1.6k
Rosa N. Schnyer United States 27 476 0.4× 394 0.5× 178 0.5× 803 2.5× 134 0.6× 65 2.5k
Kathrin Bernardy Germany 22 1.7k 1.3× 1.4k 1.9× 171 0.5× 491 1.5× 304 1.3× 46 2.2k
Francis E. Lotrich United States 33 811 0.6× 405 0.5× 250 0.7× 270 0.8× 268 1.1× 63 2.7k
Jacques Devulder Belgium 21 273 0.2× 740 1.0× 390 1.1× 266 0.8× 178 0.7× 64 1.6k

Countries citing papers authored by Elena P. Calandre

Since Specialization
Citations

This map shows the geographic impact of Elena P. Calandre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena P. Calandre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena P. Calandre more than expected).

Fields of papers citing papers by Elena P. Calandre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena P. Calandre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena P. Calandre. The network helps show where Elena P. Calandre may publish in the future.

Co-authorship network of co-authors of Elena P. Calandre

This figure shows the co-authorship network connecting the top 25 collaborators of Elena P. Calandre. A scholar is included among the top collaborators of Elena P. Calandre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena P. Calandre. Elena P. Calandre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Molina-Barea, Rocío, et al.. (2021). Marital Adjustment in Patients with Cancer: Association with Psychological Distress, Quality of Life, and Sleep Problems. International Journal of Environmental Research and Public Health. 18(13). 7089–7089. 12 indexed citations
2.
Calandre, Elena P., Fernando Rico‐Villademoros, & Mahmoud Slim. (2016). Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use. Expert Review of Neurotherapeutics. 16(11). 1263–1277. 164 indexed citations
3.
Rico‐Villademoros, Fernando, Mahmoud Slim, & Elena P. Calandre. (2015). Amitriptyline for the treatment of fibromyalgia: a comprehensive review. Expert Review of Neurotherapeutics. 15(10). 1123–1150. 38 indexed citations
4.
Calandre, Elena P., Fernando Rico‐Villademoros, & Mahmoud Slim. (2015). An update on pharmacotherapy for the treatment of fibromyalgia. Expert Opinion on Pharmacotherapy. 16(9). 1347–1368. 78 indexed citations
5.
Molina-Barea, Rocío, et al.. (2014). Lobular Breast Cancer Metastasis to the Colon, the Appendix and the Gallbladder. Breast Care. 9(6). 428–430. 9 indexed citations
6.
Garcia‐Leiva, Juan M., et al.. (2014). Celiac symptoms in patients with fibromyalgia: a cross-sectional study. Rheumatology International. 35(3). 561–567. 14 indexed citations
7.
8.
Rodriguez‐Lopez, C.M., et al.. (2012). Ozone Therapy as Add-On Treatment in Fibromyalgia Management by Rectal Insufflation: An Open-Label Pilot Study. The Journal of Alternative and Complementary Medicine. 19(3). 238–242. 21 indexed citations
9.
Calandre, Elena P., Fernando Rico‐Villademoros, & C.M. Rodriguez‐Lopez. (2012). Monotherapy or Combination Therapy for Fibromyalgia Treatment?. Current Rheumatology Reports. 14(6). 568–575. 19 indexed citations
10.
Calandre, Elena P. & Fernando Rico‐Villademoros. (2012). The Role of Antipsychotics in the Management of Fibromyalgia. CNS Drugs. 26(2). 135–153. 33 indexed citations
11.
Calandre, Elena P., et al.. (2011). Trazodone plus pregabalin combination in the treatment of fibromyalgia: a two-phase, 24-week, open-label uncontrolled study. BMC Musculoskeletal Disorders. 12(1). 95–95. 35 indexed citations
12.
Rodriguez‐Lopez, C.M., et al.. (2010). Trazodone for the treatment of fibromyalgia: an open-label, 12-week study. BMC Musculoskeletal Disorders. 11(1). 204–204. 30 indexed citations
13.
Calandre, Elena P., et al.. (2009). Cognitive effects of long-term treatment with phenobarbital and valproic acid in school children. Acta Neurologica Scandinavica. 81(6). 504–506. 41 indexed citations
14.
Rico‐Villademoros, Fernando, et al.. (2009). Efficacy and tolerability of intravenous methylergonovine in migraine female patients attending the emergency department: a pilot open-label study. Head & Face Medicine. 5(1). 21–21. 5 indexed citations
15.
Calandre, Elena P., et al.. (2007). Pregabalin Augmentation of Quetiapine Therapy in the Treatment of Fibromyalgia: An Open-Label, Prospective Trial. Pharmacopsychiatry. 40(2). 68–71. 24 indexed citations
16.
Calandre, Elena P., Javier Luis López Hidalgo, & Fernando Rico‐Villademoros. (2006). Use of ziprasidone in patients with fibromyalgia: a case series. Rheumatology International. 27(5). 473–476. 18 indexed citations
17.
Arroyo, Santiago, Martin J. Brodie, John S. Duncan, et al.. (2005). A randomised open-label study of tiagabine given two or three times daily in refractory epilepsy. Seizure. 14(2). 81–84. 7 indexed citations
18.
Rico‐Villademoros, Fernando, et al.. (2004). Atypical antipsychotics in the treatment of fibromyalgia: a case series with olanzapine. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 29(1). 161–164. 26 indexed citations
19.
Calandre, Elena P., et al.. (1992). Fármacos ansiolíticos e hipnóticos.. SHILAP Revista de lepidopterología. 12. 29–36. 1 indexed citations
20.
Calandre, Elena P., et al.. (1992). The Effect of Chronic Phenytoin Treatment on Serum Lipid Profile in Adult Epileptic Patients. Epilepsia. 33(1). 154–157. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fernando Rico‐Villademoros Breakdown of academic impact, for papers by Uma Sharma Breakdown of academic impact, for papers by Michael Spaeth Breakdown of academic impact, for papers by Henning Værøy Breakdown of academic impact, for papers by Madelaine M. Wohlreich Breakdown of academic impact, for papers by Luke Parkitny Breakdown of academic impact, for papers by Rosa N. Schnyer Breakdown of academic impact, for papers by Kathrin Bernardy Breakdown of academic impact, for papers by Francis E. Lotrich Breakdown of academic impact, for papers by Jacques Devulder
Rankless by CCL
2026